| GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand L Yang, CC Chang, Z Sun, D Madsen, H Zhu, SB Padkjær, X Wu, ... Nature medicine 23 (10), 1158-1166, 2017 | 595 | 2017 |
| Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression CC Chang, JD Heller, J Kuo, RCC Huang Proceedings of the National Academy of Sciences 101 (36), 13239-13244, 2004 | 171 | 2004 |
| Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors R Park, CC Chang, YC Liang, Y Chung, RA Henry, E Lin, DE Mold, ... Clinical Cancer Research 11 (12), 4601-4609, 2005 | 99 | 2005 |
| Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel CC Chang, YC Liang, A Klutz, CI Hsu, CF Lin, DE Mold, TC Chou, YC Lee, ... Cancer chemotherapy and pharmacology 58, 640-653, 2006 | 47 | 2006 |
| A novel high-throughput screening method for microbial transglutaminases with high specificity toward Gln141 of human growth hormone X Zhao, AC Shaw, J Wang, CC Chang, J Deng, J Su Journal of Biomolecular screening 15 (2), 206-212, 2010 | 42 | 2010 |
| Survivin-dependent and-independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid RCC Huang, CC Chang, D Mold Seminars in oncology 33 (4), 479-485, 2006 | 38 | 2006 |
| Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model C Andersson, CS Wenander, PA Usher, JB Hebsgaard, BC Sondergaard, ... Clinical & Experimental Immunology 177 (1), 219-233, 2014 | 33 | 2014 |
| Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening W Yang, SB Padkjær, J Wang, Z Sun, B Shan, L Yang, H Chen, L Kang, ... Journal of biotechnology 260, 18-30, 2017 | 29 | 2017 |
| Method for treatment of tumors using nordihydroguaiaretic acid derivatives RCC Huang, JD Heller, CC Chang US Patent 6,608,108, 2003 | 27* | 2003 |
| Methods and compositions for delivery of catecholic butanes for treatment of obesity J Heller, N Frazer, CC Chang, E Lin, RCC Huang | 25 | 2004 |
| Method for treatment of tumors using nordihydroguaiaretic acid derivatives RCC Huang, JD Heller, CC Chang US Patent 8,318,815, 2012 | 21 | 2012 |
| Methods for delivery of catecholic butanes for treatment of tumors RCC Huang, R Park, CC Chang, YC Liang, D Mold, E Lin, J Heller, ... US Patent 7,728,036, 2010 | 17 | 2010 |
| Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model SM Atkinson, A Nansen, PA Usher, BC Sondergaard, CR Mackay, ... Autoimmunity 48 (7), 460-470, 2015 | 12 | 2015 |
| Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection RCC Huang, JR Hwu, MH Hsu, DE Mold, YC Lee, CC Chang WO Patent App. 2,006,041,902, 2006 | 10 | 2006 |
| Transglutaminase variants with improved specificity Z Hu, X Zhao, J Wang, CC Chang, L Norskov-Lauritsen US Patent App. 12/310,275, 2009 | 9 | 2009 |
| Transglutaminase variants with improved specificity S Hu, Z Xin, W Jianhua, C Chang, L Nørskov-Lauritsen, J Su US Patent App. 12/527,451, 2010 | 8 | 2010 |
| Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors RCC Huang, R Park, CC Chang, YC Liang, D Mold, E Lin, J Heller, ... US Patent App. 12/790,894, 2011 | 4 | 2011 |
| MIC-1 receptor and uses thereof J Su, W Yang, CC Chang, L Yang, Z Sun, H Chen, HE Zhenhua, Z Wang, ... US Patent 11,105,818, 2021 | 3 | 2021 |
| MIC1 receptor and uses thereof J Su, W Yang, C Chang, L Yang, Z Sun, H Chen, Z He, Z Wang, ... US Patent App. 20,190/025,332, 2019 | | 2019 |
| Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection DE Mold, YC Lee, CC Chang, RCC Huang, JR Hwu, MH Hsu CA Patent App. 002,583,336 A, 2006 | | 2006 |
